United Therapeutics Corporation
US ˙ NasdaqGS ˙ US91307C1027

SecurityUTHR / United Therapeutics Corporation
InstitutionDimensional Fund Advisors Lp
Latest Disclosed Ownership512,739 shares
Latest Disclosed Value $ 304,029,148
Dimensional Fund Advisors Lp reports 2.93% decrease in ownership of UTHR / United Therapeutics Corporation

On May 7, 2026 - Dimensional Fund Advisors Lp filed a 13F-HR form disclosing ownership of 512,739 shares of United Therapeutics Corporation (US:UTHR) valued at $304,043,972 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 12, 2026 disclosing 528,210 shares of United Therapeutics Corporation. This represents a change in shares of -2.93% during the quarter. The current value of the position is $281,939,794 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-07 2026-03-31 13F UNITED THERAPEUTICS CORP DEL COM 91307C102 512,739 -15,471 -2.93 304,029 18.11 0.0136
2026-02-12 2025-12-31 13F UNITED THERAPEUTICS CORP DEL COM 91307C102 528,210 15,394 3.00 257,405 19.73 0.0540
2025-11-12 2025-09-30 13F UNITED THERAPEUTICS CORP DEL COM 91307C102 512,816 -60,918 -10.62 214,995 30.42 0.0461
2025-08-12 2025-06-30 13F UNITED THERAPEUTICS CORP DEL COM 91307C102 573,734 -50,977 -8.16 164,854 -14.39 0.0382
2025-05-13 2025-03-31 13F UNITED THERAPEUTICS CORP DEL COM 91307C102 624,711 4,145 0.67 192,571 -12.06 0.0479
2025-02-13 2024-12-31 13F UNITED THERAPEUTICS CORP DEL COM 91307C102 620,566 -466 -0.08 218,979 -1.60 0.0526
2024-11-07 2024-09-30 13F UNITED THERAPEUTICS CORP DEL COM 91307C102 621,032 35,063 5.98 222,548 19.23 0.0540
2024-08-09 2024-06-30 13F UNITED THERAPEUTICS CORP DEL COM 91307C102 585,969 22,683 4.03 186,656 44.25 0.0488
2024-05-10 2024-03-31 13F UNITED THERAPEUTICS CORP DEL COM 91307C102 563,286 1,336 0.24 129,398 4.72 0.0350
2024-02-07 2023-12-31 13F UNITED THERAPEUTICS CORP DEL COM 91307C102 561,950 9,962 1.80 123,566 -0.89 0.0361
2023-11-09 2023-09-30 13F UNITED THERAPEUTICS CORP DEL COM 91307C102 551,988 17,234 3.22 124,678 5.62 0.0409
2023-08-09 2023-06-30 13F UNITED THERAPEUTICS CORP DEL COM 91307C102 534,754 17,077 3.30 118,045 1.83 0.0376
2023-05-12 2023-03-31 13F UNITED THERAPEUTICS CORP DEL COM 91307C102 517,677 22,169 4.47 115,930 84,519.71 0.0391
2023-02-09 2022-12-31 13F UNITED THERAPEUTICS CORP DEL COM 91307C102 495,508 -33,014 -6.25 138 -99.88 0.0407
2022-11-10 2022-09-30 13F UNITED THERAPEUTICS CORP DEL COM 91307C102 528,522 4,174 0.80 110,659 -10.44 0.0425
2022-08-12 2022-06-30 13F UNITED THERAPEUTICS CORP DEL COM 91307C102 524,348 -37,618 -6.69 123,560 22.56 0.0443
2022-05-13 2022-03-31 13F UNITED THERAPEUTICS CORP DEL COM 91307C102 561,966 -12,270 -2.14 100,814 -18.75 0.0311
2022-02-09 2021-12-31 13F UNITED THERAPEUTICS CORP DEL COM 91307C102 574,236 -26,423 -4.40 124,078 11.91 0.0375
2021-11-12 2021-09-30 13F UNITED THERAPEUTICS CORP DEL COM 91307C102 600,659 -56,936 -8.66 110,873 -6.02 0.0357
2021-08-12 2021-06-30 13F UNITED THERAPEUTICS CORP DEL COM 91307C102 657,595 -96,388 -12.78 117,973 -6.46 0.0374
2021-05-14 2021-03-31 13F UNITED THERAPEUTICS CORP DEL COM 91307C102 753,983 -132,351 -14.93 126,114 -6.26 0.0417
2021-03-08 2020-12-31 13F/A-2 UNITED THERAPEUTICS CORP DEL COM 91307C102 886,334 -16,421 -1.82 134,529 47.55 0.0486
2021-02-11 2020-12-31 13F UNITED THERAPEUTICS CORP DEL COM 91307C102 886,334 -16,421 134,529 48,584.7242
2020-11-12 2020-09-30 13F UNITED THERAPEUTICS CORP DEL COM 91307C102 902,755 110,152 13.90 91,178 -4.93 0.0387
2020-08-13 2020-06-30 13F UNITED THERAPEUTICS CORP DEL COM 91307C102 792,603 -106,404 -11.84 95,902 12.49 0.0422
2020-05-14 2020-03-31 13F UNITED THERAPEUTICS CORP DEL COM 91307C102 899,007 14,674 1.66 85,254 9.46 0.0444
2020-02-14 2019-12-31 13F UNITED THERAPEUTICS CORP DEL COM 91307C102 884,333 34,137 4.02 77,889 14.87 0.0284
2019-11-12 2019-09-30 13F UNITED THERAPEUTICS CORP DEL COM 91307C102 850,196 580 0.07 67,806 2.24 0.0263
2019-08-13 2019-06-30 13F UNITED THERAPEUTICS CORP DEL COM 91307C102 849,616 -225,227 -20.95 66,319 -47.43 0.0258
2019-08-12 2019-03-31 13F/A-2 UNITED THERAPEUTICS CORP DEL COM 91307C102 1,074,843 -14,139 -1.30 126,155 6.39 0.0502
2019-05-10 2019-03-31 13F UNITED THERAPEUTICS CORP DEL COM 91307C102 1,074,843 -14,139 126,155
2019-02-26 2018-12-31 13F/A-1 UNITED THERAPEUTICS CORP DEL COM 91307C102 1,088,982 29,427 2.78 118,583 -12.48 0.0537
2019-02-13 2018-12-31 13F UNITED THERAPEUTICS CORP DEL COM 91307C102 1,088,982 29,427 118,583
2018-11-13 2018-09-30 13F UNITED THERAPEUTICS CORP DEL COM 91307C102 1,059,555 68,870 6.95 135,493 20.88 0.0516
2018-08-10 2018-06-30 13F UNITED THERAPEUTICS CORP DEL COM 91307C102 990,685 32,611 3.40 112,093 4.13 0.0447
2018-05-11 2018-03-31 13F UNITED THERAPEUTICS CORP DEL COM 91307C102 958,074 10,129 1.07 107,649 -23.25 0.0449
2018-02-12 2017-12-31 13F UNITED THERAPEUTICS CORP DEL COM 91307C102 947,945 149,852 18.78 140,251 49.95 0.0581
2017-11-13 2017-09-30 13F UNITED THERAPEUTICS CORP DEL COM 91307C102 798,093 71,333 9.82 93,531 -0.80 0.0409
2017-08-11 2017-06-30 13F UNITED THERAPEUTICS CORP DEL COM 91307C102 726,760 266,790 58.00 94,286 51.41 0.0435
2017-05-12 2017-03-31 13F UNITED THERAPEUTICS CORP DEL COM 91307C102 459,970 8,759 1.94 62,272 -3.78 0.0298
2017-02-09 2016-12-31 13F UNITED THERAPEUTICS CORP DEL COM 91307C102 451,211 153,165 51.39 64,718 83.92 0.0323
2016-11-10 2016-09-30 13F UNITED THERAPEUTICS CORP DEL COM 91307C102 298,046 86,970 41.20 35,189 57.42 0.0190
2016-08-09 2016-06-30 13F UNITED THERAPEUTICS CORP DEL COM 91307C102 211,076 9,258 4.59 22,354 -0.59 0.0129
2016-05-13 2016-03-31 13F UNITED THERAPEUTICS CORP DEL COM 91307C102 201,818 63,525 45.94 22,487 3.82 0.0135
2016-02-10 2015-12-31 13F UNITED THERAPEUTICS CORP DEL COM 91307C102 138,293 4,251 3.17 21,660 23.07 0.0135
2015-11-13 2015-09-30 13F UNITED THERAPEUTICS CORP DEL COM 91307C102 134,042 -54,047 -28.73 17,600 -46.20 0.0116
2015-08-14 2015-06-30 13F UNITED THERAPEUTICS CORP DEL COM 91307C102 188,089 4,236 2.30 32,716 3.19 0.0200
2015-05-14 2015-03-31 13F UNITED THERAPEUTICS CORP DEL COM 91307C102 183,853 1,341 0.73 31,706 34.15 0.0200
2015-02-06 2014-12-31 13F UNITED THERAPEUTICS CORP DEL COM 91307C102 182,512 -1,565 -0.85 23,635 -0.23 0.0155
2014-11-13 2014-09-30 13F UNITED THERAPEUTICS CORP DEL COM 91307C102 184,077 13,549 7.95 23,689 56.97 0.0168
2014-08-08 2014-06-30 13F UNITED THERAPEUTICS CORP DEL COM 91307C102 170,528 -581 -0.34 15,091 -6.21 0.0105
2014-05-14 2014-03-31 13F UNITED THERAPEUTICS CORP DEL COM 91307C102 171,109 2,421 1.44 16,090 -15.64 0.0120
2014-02-12 2013-12-31 13F UNITED THERAPEUTICS CORP DEL COM 91307C102 168,688 4,284 2.61 19,074 47.15 0.0149
2013-11-13 2013-09-30 13F UNITED THERAPEUTICS CORP DEL COM 91307C102 164,404 8,299 5.32 12,962 26.19 0.0112
2013-08-15 2013-06-30 13F UNITED THERAPEUTICS CORP DEL COM 91307C102 156,105 156,105 10,272 0.0097
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.